Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-28
1997-02-18
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 514 61, 514 62, 536 172, 536 63, 536 64, 536 65, 536 55, 536 551, 536 552, A61K 31715, A61K 3173, C07H 306
Patent
active
056042078
ABSTRACT:
The inventive compounds are analogues of sialyl Le.sup.x that inhibit cellular adhesion between a selectin and cells that express sialyl Le.sup.x on their surfaces, and their synthetic intermediates. An inventive compound has structure A, ##STR1## wherein Z is hydrogen, C.sub.1 -C.sub.6 acyl or ##STR2## Y is C(O), SO.sub.2, HNC(O), OC(O) or SC(O); R.sup.1 is an aryl, a substituted aryl or a phenyl C.sub.1 -C.sub.3 alkylene group, wherein an aryl group has one five- or six-membered aromatic ring, a fused five/six-membered aromatic ring, or two fused six-membered aromatic rings, which rings are hydrocarbyl, monooxahydrocarbyl, monothiahydrocarbyl, monoazahydrocarbyl or diazahydrocarbyl rings, and a substituted aryl group is an aryl group having a halo, trifluoromethyl, nitro, C.sub.1 -C.sub.18 alkyl, C.sub.1 -C.sub.18 alkoxy, amino, mono-C.sub.1 -C.sub.18 alkylamino, di-C.sub.1 -C.sub.18 alkylamino, benzylamino, C.sub.1 -C.sub.18 alkylbenzylamino, C.sub.1 -C.sub.18 thioalkyl or C.sub.1 -C.sub.18 alkyl carboxamido substituent, or
REFERENCES:
patent: 5143712 (1992-09-01), Brandley et al.
patent: 5211936 (1993-05-01), Brandley
patent: 5211937 (1993-05-01), Brandley et al.
patent: 5324663 (1994-06-01), Lowe
patent: 5352670 (1994-10-01), Venot et al.
Green et al. Biochem. Biiophys. Res. Commun. Oct. 15, 1992, 188(1), 244-251.
Needham et al. Proc. Nat. Acad. Sci. USA Feb. 1993, 90, 1359-1363.
DeFrees et al. J. Am. Chem. Soc. Aug. 11, 1993, 115(16), 7549-7550.
Tyrell et al. Proc. Natl. Acad. Sci. USA 1991, 88, 10372-10376.
Zhou et al. J. Cell Biol. 1991, 115(2), 557-563.
Danishefsky et al. J. Am Chem. Soc. 1992, 114(21), 8331-8333.
Phillips, et al. (1990) "ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, Sialyl-Le.sup.x ", Science, 250: 1130-1131.
Walz, et al. (1990) "Recognition by ELAM-1 of Sialyl-Le.sup.x determinant on myeloid and tumor cells", Science, 250:1132-1135.
Munro, et al. (1992) "Expression of Sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues", American Journal of Pathology, 141(6):1397-1408.
Ball, et al. (1991) "Structural requirements for the carbohydrate ligand of E-selectin", Proceedings of the National Academy of Sciences, 88:10372-10376.
DeFrees Shawn A.
Gaeta Federico C. A.
Gaudino John J.
Hayashi Masaji
Zheng Zhongli
Cytel Corporation
Fonda Kathleen Kahler
Kunz Gary L.
LandOfFree
Sialyl Le.sup.x analogues as inhibitors of cellular adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sialyl Le.sup.x analogues as inhibitors of cellular adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sialyl Le.sup.x analogues as inhibitors of cellular adhesion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1602571